NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 45 filers reported holding NEON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $222,000 | -17.2% | 188,277 | +21.0% | 0.00% | -33.3% |
| Q3 2019 | $268,000 | -48.9% | 155,619 | +40.8% | 0.00% | -57.1% |
| Q2 2019 | $524,000 | -39.7% | 110,561 | -17.9% | 0.01% | -46.2% |
| Q1 2019 | $869,000 | +214.9% | 134,593 | +144.9% | 0.01% | +160.0% |
| Q4 2018 | $276,000 | – | 54,954 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $16,756,000 | 9.49% |
| MYDA Advisors LLC | 155,000 | $267,000 | 0.12% |
| Endurant Capital Management LP | 193,052 | $332,000 | 0.12% |
| FNY Investment Advisers, LLC | 210,000 | $361,000 | 0.11% |
| HARVARD MANAGEMENT CO INC | 505,871 | $870,000 | 0.08% |
| Alambic Investment Management, L.P. | 25,800 | $44,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 209,307 | $360,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 155,619 | $268,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 116,600 | $201,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 14,371 | $25,000 | 0.00% |